AnHeart Therapeutics
Biotechnology ResearchNew York, United States51-200 Employees
AnHeart is now a Nuvation Bio company. For the latest news and updates please visit www.linkedin.com/company/nuvationbio/
Insights
Gathering insights about AnHeart Therapeutics…
Similar companies to AnHeart Therapeutics
Innovent Biologics
5K
$1BZai Lab
1K$100M$1BBeiGene
10K$1BAscentage Pharma
201$50M$100MAkeso
102$10MCStone Pharmaceuticals
210$50M$100MEverest Medicines
201$50M$100MAlphamab Oncology
201Adlai Nortye
55$10M$50M
AnHeart Therapeutics Tech Stack
AnHeart Therapeutics uses 8 technology products and services including Google Analytics, Google Font API, jQuery, and more. Explore AnHeart Therapeutics's tech stack below.
- Google AnalyticsAnalytics
- Google Font APIFont Scripts
- jQueryJavascript Libraries
- SlickJavascript Libraries
- ElementorPage Builders
- Amazon Web ServicesPlatform As A Service
- X-XSS-ProtectionSecurity
- Apache HTTP ServerWeb Servers
Media & News
AnHeart Therapeutics's Email Address Formats
AnHeart Therapeutics uses at least 1 format(s):
| AnHeart Therapeutics Email Formats | Percentage |
| FLast@anhearttherapeutics.com | 49% |
| First@anhearttherapeutics.com | 1% |
| LastFirst@anhearttherapeutics.com | 1% |
| FLast@anhearttherapeutics.com | 49% |
Frequently Asked Questions
Where is AnHeart Therapeutics's headquarters located?
AnHeart Therapeutics's main headquarters is located at 5 Penn Plaza, 23rd floor New York, New York 10001 US. The company has employees across 2 continents, including North AmericaAsia. What is AnHeart Therapeutics's official website and social media links?
AnHeart Therapeutics's official website is anhearttherapeutics.com and has social profiles on LinkedIn.How much revenue does AnHeart Therapeutics generate?
As of April 2024, AnHeart Therapeutics's annual revenue reached $15M. What is AnHeart Therapeutics's SIC code NAICS code?
AnHeart Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does AnHeart Therapeutics have currently?
As of April 2024, AnHeart Therapeutics has approximately 51 employees across 2 continents, including North AmericaAsia. Key team members include Chief Corporate Affairs Officer: C. A.Chief Business Officer: E. L.Vice President Clinical Operations (u.S): J. K.. Explore AnHeart Therapeutics's employee directory with LeadIQ.What industry does AnHeart Therapeutics belong to?
AnHeart Therapeutics operates in the Biotechnology Research industry. What technology does AnHeart Therapeutics use?
AnHeart Therapeutics's tech stack includes Google AnalyticsGoogle Font APIjQuerySlickElementorAmazon Web ServicesX-XSS-ProtectionApache HTTP Server. What is AnHeart Therapeutics's email format?
AnHeart Therapeutics's email format typically follows the pattern of . Find more AnHeart Therapeutics email formats with LeadIQ. How much funding has AnHeart Therapeutics raised to date?
As of April 2024, AnHeart Therapeutics has raised $61M in funding. The last funding round occurred on Dec 14, 2021 for $61M.When was AnHeart Therapeutics founded?
AnHeart Therapeutics was founded in 2018.
Company Overview
- Headquarters
- 5 Penn Plaza, 23rd floor New York, New York 10001 US
- Website
- anhearttherapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2018
- Employees
- 51-200
Media & News
Funding & Financials
- $61M
AnHeart Therapeutics has raised a total of $61M of funding over 2 rounds. Their latest funding round was raised on Dec 14, 2021 in the amount of $61M.
- $10M$50M
AnHeart Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $61M
AnHeart Therapeutics has raised a total of $61M of funding over 2 rounds. Their latest funding round was raised on Dec 14, 2021 in the amount of $61M.
- $10M$50M
AnHeart Therapeutics's revenue is in the range of $10M$50M
Company Leadership
C. A.Chief Corporate Affairs Officer
E. L.Chief Business Officer- J. K.Vice President Clinical Operations (u.S)
- R. L.Vice President Clinical Development
B. Y.Co-Founder
Employee Directory
- H. D.Senior Director Biomarkers, Head Of Translational Medicine
- R. L.Vice President Clinical Development
- J. V.Sr Director, Program Management
- L. V.Senior Director, Clinical Quality Assurance
- D. S.Senior Director Of Regulatory Affairs
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
